Multiple Myeloma Management 对比 Multiple Myeloma [MM] 的使用情况和统计数据

Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Myeloma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Multiple Myeloma @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Multiple Myeloma content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients
  • Apple 应用商店
  • 免费
  • 医疗

商店排名

- -

Multiple Myeloma Management与Multiple Myeloma [MM]排名比较

对比 Multiple Myeloma Management 与 Multiple Myeloma [MM] 在过去 28 天内的排名趋势

排名

没有可用的数据

Multiple Myeloma Management 对比 Multiple Myeloma [MM] 的排名,按国家/地区比较

对比 Multiple Myeloma Management 与 Multiple Myeloma [MM] 在过去 28 天内的排名趋势

无数据可显示

通过免费试用版比较任何网站

开始使用
Multiple Myeloma Management VS.
Multiple Myeloma [MM]

十二月 19, 2024